Terms: = Liver cancer AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
19 results:
1. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
[TBL] [Abstract] [Full Text] [Related]
2. A deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study.
Azhie A; Sharma D; Sheth P; Qazi-Arisar FA; Zaya R; Naghibzadeh M; Duan K; Fischer S; Patel K; Tsien C; Selzner N; Lilly L; Jaeckel E; Xu W; Bhat M
Lancet Digit Health; 2023 Jul; 5(7):e458-e466. PubMed ID: 37210229
[TBL] [Abstract] [Full Text] [Related]
3. Immunotherapy with Autoimmune Complication in Renal cancer.
Sunil SP; Kumar S; Hussaini S; Kandula S
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116021
[TBL] [Abstract] [Full Text] [Related]
4. Identification of 5 Hub Genes Related to the Early diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
[TBL] [Abstract] [Full Text] [Related]
5. Resting energy expenditure in cancer patients: Agreement between predictive equations and indirect calorimetry.
Barcellos PS; Borges N; Torres DPM
Clin Nutr ESPEN; 2021 Apr; 42():286-291. PubMed ID: 33745594
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract] [Full Text] [Related]
7. Differential expression and diagnostic significance of P53, MutS homologs 2, tropomyosin-4 in alpha-fetoprotein-negative hepatocellular carcinoma.
Gong X; Huang A
J Clin Lab Anal; 2020 Aug; 34(8):e23353. PubMed ID: 32363617
[TBL] [Abstract] [Full Text] [Related]
8. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies.
Hass P; Mohnike K; Kropf S; Brunner TB; Walke M; Albers D; Petersen C; Damm R; Walter F; Ricke J; Powerski M; Corradini S
Brachytherapy; 2019; 18(6):823-828. PubMed ID: 31522972
[TBL] [Abstract] [Full Text] [Related]
9. [Plasma mannan?binding lectin and MBL?associated serine protease 2 in patients with hepatocellular carcinoma].
Li J; Zhu LY; Zuo DM; Zhang LY; Lu X; Chen ZL; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Dec; 37(12):1667-1672. PubMed ID: 29292263
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
[TBL] [Abstract] [Full Text] [Related]
11. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract] [Full Text] [Related]
12. cancer risk in patients with pyogenic liver abscess: a nationwide cohort study.
Kao WY; Hwang CY; Chang YT; Su CW; Hou MC; Lin HC; Lee FY; Lee SD; Wu JC
Aliment Pharmacol Ther; 2012 Sep; 36(5):467-76. PubMed ID: 22779737
[TBL] [Abstract] [Full Text] [Related]
13. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract] [Full Text] [Related]
15. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
Gervasini G; García-Martín E; Ladero JM; Pizarro R; Sastre J; Martínez C; García M; Diaz-Rubio M; Agúndez JA
BMC Cancer; 2007 Jul; 7():118. PubMed ID: 17605821
[TBL] [Abstract] [Full Text] [Related]
16. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
Giannelli G; Fransvea E; Trerotoli P; Beaugrand M; Marinosci F; Lupo L; Nkontchou G; Dentico P; Antonaci S
Clin Chim Acta; 2007 Aug; 383(1-2):147-52. PubMed ID: 17582392
[TBL] [Abstract] [Full Text] [Related]
17. Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.
Ikeda K; Saitoh S; Kobayashi M; Suzuki Y; Suzuki F; Tsubota A; Arase Y; Murashima N; Chayama K; Kumada H
J Gastroenterol Hepatol; 2001 Apr; 16(4):406-15. PubMed ID: 11354279
[TBL] [Abstract] [Full Text] [Related]
18. The application of minimal access procedures in infants, children, and young adults with pediatric malignancies.
Saenz NC; Conlon KC; Aronson DC; LaQuaglia MP
J Laparoendosc Adv Surg Tech A; 1997 Oct; 7(5):289-94. PubMed ID: 9453873
[TBL] [Abstract] [Full Text] [Related]
19. Alcoholism: independent predictor of survival in patients with head and neck cancer.
Deleyiannis FW; Thomas DB; Vaughan TL; Davis S
J Natl Cancer Inst; 1996 Apr; 88(8):542-9. PubMed ID: 8606383
[TBL] [Abstract] [Full Text] [Related]
